miltefosine has been researched along with epirubicin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Berger, M; Karaivanova, M; Konstantinov, S; Martinova, Y; Petkova, S; Topashka-Ancheva, M | 1 |
2 other study(ies) available for miltefosine and epirubicin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Miltefosine decreases the cytotoxic effect of epirubicine and cyclophosphamide on mouse spermatogenic, thymic and bone marrow cells.
Topics: Animals; Antineoplastic Agents; Bone Marrow Cells; Chromosome Aberrations; Chromosomes; Cyclophosphamide; Drug Interactions; Epirubicin; Female; Male; Mice; Mice, Inbred C57BL; Mutagens; Phosphorylcholine; Spermatogenesis; Spermatozoa; Testis; Thymus Gland | 2006 |